HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Ecabet

HCID 65781
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
33159-27-2
Standard SMILES
CC(C)c1cc2c(cc1S(=O)(=O)O)[C@@]1(C)CCC[C@@](C)(C(=O)O)[C@@H]1CC2
InChIKey
IWCWQNVIUXZOMJ-MISYRCLQSA-N
Molecular formula
C20H28O5S
Average molar mass
380.5 g/mol
Monoisotopic mass
380.16574516

Overview

Ecabet is a diterpenoid.

Names & identifiers

Preferred name
Ecabet
IUPAC
(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-6-sulfo-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid
English name
Ecabet
Molecular formula
C20H28O5S
Molecular weight
380.5

Names & synonyms

Ecabet33159-27-2Ecabetum12-sulfodehydroabietic acidDTXSID70468812K02669KWPDTXCID5026881(1R,4AS,10AR)-1,4A-DIMETHYL-7-(PROPAN-2-YL)-6-SULFO-1,2,3,4,4A,9,10,10A-OCTAHYDROPHENANTHRENE-1-CARBOXYLIC ACID1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium saltRefChem:136197Ecabet [INN](1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-6-sulfo-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid
Show more names
Abietic acid, dehydro-6-sulfo- (6CI)Podocarpa-8,11,13-trien-15-oic acid, 13-isopropyl-12-sulfo- (8CI)1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-, (1R,4aS,10aR)-1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-, [1R-(1α,4aβ,10aα)]-
Ecabet (INN)13-Isopropyl-12-sulfopodocarpa-8,11,13-trien-15-oic acidC20H28O5SNCGC00181160-01Ecabetum [INN-Latin](1R,4aS,10aR)-7-Isopropyl-1,4a-dimethyl-6-sulfo-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylic acidUNII-2K02669KWPMFCD11044526

Database identifiers

CAS
33159-27-2、86408-72-2
PubChem CID
65781
DTXSID
DTXSID7046881
ChEMBL
CHEMBL2104585
ChEBI
CHEBI:135593
UNII
2K02669KWP
Nikkaji
J550.676J

Properties

Computed structural properties

XLogP
4.3
Topological polar surface area
100 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
5
Rotatable bonds
3
Heavy atoms
26
Formal charge
0
Complexity
666

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
Solubility4.26e-03 g/L
Physical DescriptionSolid

Physicochemical properties

alpha
25 · D25 +72.4° (c = 2.5 in alcohol)
Density
1.241 · 1.241±0.06 g/cm3(Predicted)
storage temp.
Sealed in dry,Room Temperature
pka
-0.31 · -0.31±0.60(Predicted)
InChIKey
IWCWQNVIUXZOMJ-MISYRCLQSA-N
SMILES
[C@@]1(C)(C(O)=O)[C@@]2([H])[C@@](C)(C3=C(CC2)C=C(C(C)C)C(S(O)(=O)=O)=C3)CCC1
FDA UNII
2 K02669KWP · 2K02669KWP

Chemistry & industry

Pharmacology

Mechanism of Action · 1 item

Ecabet reduces the survival of H. pylori in the stomach and inhibits pepsin activity in the gastric juice of experimental animals. Here we have investigated the effects of ecabet on some of the factors involved in the dynamics of the mucosal barrier, i.e. pepsins and mucins. Pepsin, acid and Helicobacter pylori are major factors in the pathophysiology of peptic ulcer disease and reflux oesophagitis. Ecabet also acts as an inhibitor of H. pylori NADPH oxidase as well as urease. Inhibition of these enzymes prevents bacterial adhesion to gastric mucosa.

MeSH Pharmacological Classification · 4 items

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.

Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES).

Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved.

Cellular LocationsCytoplasm

Applications

UsesEcabet sodium (TA-2711) is currently applied to some clinical gastrointestinal disease by inhibiting the ROS production and improving Helicobacter pylori eradication[1]. Ecabet sodium reduces apoptosis[2]

Additional notes

DefinitionChEBI: Ecabet is a diterpenoid.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes